R-CHOP/Ibrutinib Alternating with R-DHAP Regimen

Preferred Label : R-CHOP/Ibrutinib Alternating with R-DHAP Regimen;

NCIt synonyms : R-CHOP-Ibrutinib/R-DHAP; R-CHOP-Ibrutinib/R-DHAP Regimen; Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine Plus Ibrutinib Alternating with Rituximab Plus Cisplatin/Cytarabine/Dexamethasone; Cyclophosphamide/Doxorubicin/Prednisone/Rituximab/Vincristine/Ibrutinib-Rituximab/Cisplatin/Cytarabine/Dexamethasone; R-CHOP-Ibrutinib Alternating with R-DHAP;

NCIt related terms : IR-CHOP/R-DHAP (rituximab-blit); IR-CHOP/R-DHAP (rituximab-rite); IR-CHOP/R-DHAP (rituximab-rixi); IR-CHOP/R-DHAP (rituximab-arrx); IR-CHOP/R-DHAP (rituximab-abbs); IR-CHOP/R-DHAP; IR-CHOP/R-DHAP (rituximab-rixa); IR-CHOP/R-DHAP (rituximab-pvvr);

NCIt definition : A regimen that alternates rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) and ibrutinib with rituximab, dexamethasone, high-dose cytarabine and cisplatin (R-DHAP) that can be used in the treatment of mantle cell lymphoma.;

Codes from synonyms : 140720; 140722; 140721; 140724; 140723; 140726; 140725; 140727;

Détails

Origin ID

C209990;

chemotherapy_regimen_has_component
- Cisplatin [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Cytarabine [NCIt concept]
- Dexamethasone [NCIt concept]
- Doxorubicin [NCIt concept]
- Ibrutinib [NCIt concept]
- Prednisone [NCIt concept]
- Rituximab [NCIt concept]
- Vincristine [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients